Search the Newsreel

Court rejects Verisk plan to cancel $2.35 billion merger

A Delaware Chancery Court has rejected Verisk's attempt to terminate its $2.35 billion merger with AccuLynx, ordering Verisk to proceed with "commercially reasonable efforts" to obtain regulatory approval. The ruling stemmed from Verisk's handling of an FTC antitrust review, which Verisk initiated by attempting …

Biotech Stocks At 52-Week Highs - HALO +20% On Q2 Results, FENC, AVLN, AMLX, CHE

(RTTNews) - The following biotech stocks reached 52-week highs on August 7, 2026, driven by key catalysts such as positive quarterly reports or upcoming clinical results. Halozyme Therapeutics Inc. (HALO) Halozyme is a biopharmaceutical company specializing in the production of proprietary enzymes and devices. …

Verisk Responds to Delaware Chancery Court Ruling Regarding AccuLynx

Verisk (Nasdaq: VRSK) has issued a statement expressing strong disagreement with a recent Delaware Chancery Court ruling concerning AccuLynx. The company acknowledges the court's expedited response but is currently evaluating its options, including a possible appeal. Verisk is a leading data analytics and technology …

Kalyan Jewellers India shares rise over 2% in today's session

VRSK Looks 39.9% Undervalued on GF Value™ Amid Legal Acquisition Mandate

Verisk Analytics (NASDAQ: VRSK) has been deemed 39.9% undervalued according to GuruFocus's GF Value™ after a Delaware judge mandated the completion of its $2.35 billion acquisition of AccuLynx. The company boasts strong fundamentals with a GF Score™ of 82/100, driven by excellent growth and …

Verisk Analytics (VRSK) Q2 Update Puts Its Pricey Valuation Back In Focus

Verisk Analytics (VRSK) Q2 2026 results show continued revenue growth and new AI initiatives, leading to renewed focus on its valuation. Despite recent stock gains and strong business fundamentals, Simply Wall St's narrative suggests the company is significantly overvalued at $191.82 compared to a …

Annaly (NLY) Stock Still Looks Cheap At Today’s Price

Annaly Capital Management (NLY) has delivered a strong 73.6% return over the past three years, and current valuations suggest its shares may still be trading below their intrinsic value. Both the Excess Returns intrinsic value model and market multiples indicate the stock is undervalued, …

Quantinno Capital Management LP Acquires 27,333 Shares of Qualys, Inc. $QLYS

Quantinno Capital Management LP significantly increased its stake in Qualys, Inc. (NASDAQ:QLYS) by 306.4% in the first quarter, purchasing 27,333 additional shares to bring its total holdings to 36,253 shares valued at approximately $3.19 million. This investment comes as Qualys reported strong quarterly earnings, …

California State Teachers Retirement System Purchases 8,199 Shares of Qualys, Inc. $QLYS

The California State Teachers Retirement System increased its holdings in Qualys, Inc. (QLYS) by 24% in the first quarter, acquiring an additional 8,199 shares to bring its total to 42,317 shares valued at $3.7 million. Qualys reported strong financial results, beating analyst expectations with …

Annaly Capital Management (NLY) Could Be 4% Undervalued On Its Higher Coupon Portfolio Shift

Annaly Capital Management (NLY) is considered 4% undervalued, with a fair value estimated at $24 per share compared to its recent closing price of $23.04. This valuation is based on the company's strategic shift to higher coupon segments (6% and 6.5%) within its Agency …

Annaly Capital Management (NLY) Draws Valuation Attention, Is The Stock Still Trading At A Discount?

Health Catalyst (NASDAQ:HCAT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS

Health Catalyst (NASDAQ:HCAT) reported stronger-than-expected Q2 earnings, with an adjusted EPS of $0.04 and revenue of $70.49 million, surpassing analyst estimates. Despite the beat, the company cut its Q3 and full-year 2026 revenue guidance due to anticipated migration-related churn and costs, leading to a …

Verisk Analytics, Inc. (VRSK) Stock Forecasts

This article provides a stock forecast for Verisk Analytics, Inc. (VRSK), a data and analytics provider for property-casualty insurers. It highlights that Verisk's earnings were mostly steady in the second quarter and includes a summary of the company's background. The report also lists related …

Qualys, Inc. (QLYS) Stock Forecasts

Morningstar has raised its fair value estimate for Qualys, Inc. (QLYS) to $170 from $139, following strong earnings results and reaccelerating top-line growth. Qualys, a cloud security and compliance solutions provider, serves over 10,000 customers globally, primarily small and medium-sized businesses. The current stock …

Health Catalyst (HCAT) Stock Price Sinks On Margin Reset Fears

Health Catalyst (HCAT) saw its stock price drop by 25% following its Q2 2026 report, despite headline numbers not indicating a collapse. The decline is attributed to investor concerns over a changing margin profile due to the sale of the Vitalware unit, the transition …

Delaware judge orders Verisk to proceed with $2.35 billion AccuLynx deal By Reuters

A Delaware judge has ordered Verisk to complete its planned $2.35 billion acquisition of AccuLynx, seven months after Verisk attempted to terminate the deal. The judge found Verisk's termination invalid, stating its "willful conduct caused the failure of a condition to closing." The acquisition, …

Avalyn Pharma (NASDAQ:AVLN) Reaches New 52-Week High - Time to Buy?

Avalyn Pharma (NASDAQ:AVLN) recently hit a new 52-week high of $33.49, closing at $32.93, with a market capitalization of $1.47 billion. Analysts maintain a "Buy" rating with a consensus price target of $59, despite the company reporting a quarterly EPS loss that missed expectations. …

Annaly (NLY) Stock Looks Undervalued Even After A 74% Return

Annaly Capital Management (NLY) stock has seen a 73.6% return over the last three years but still appears undervalued based on its Excess Returns model and earnings-based multiples. While the stock screens as undervalued with a 47.8% discount to its intrinsic value, broader valuation …

Delaware court blocks Verisk’s exit from $2.35 billion AccuLynx deal

Investing.com -- A Delaware judge has ordered Verisk Analytics to attempt to complete its proposed $2.35 billion acquisition of roofing software provider AccuLynx, Reuters reported on Friday, more than seven months after Verisk terminated the transaction. Delaware Chancery Court Judge Bonnie David ruled that …

Cyber risk management evolves with Qualys ROC

Qualys Inc. is changing cyber risk management with its new Risk Operations Center (ROC) approach, addressing the rapid weaponization of vulnerabilities by using AI-speed detection, hyper-prioritization via exploit validation, and zero-day autonomous remediation. Qualys CEO Sumedh Thakar emphasized the need to move beyond traditional …

Catalyst Bancorp Inc (CLST) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Catalyst Bancorp Inc (CLST), focusing on future EPS and revenue growth estimates. It includes current stock quotes, market capitalization, and P/E ratio, along with a peer comparison featuring other banking services companies like JPMorgan Chase & Co …

Verisk Analytics (VRSK) Q2 2026 Earnings Call Transcript

Is Qualys (QLYS) Fully Valued As Strong Q2 Results Lift Guidance?

Cazaly Resources Limited Revenue Breakdown – ASX:CAZ

9% Dividend Yield From Annaly's Best Preferred Share (NYSE:NLY.PR.I)

The article evaluates Annaly Capital Management's preferred shares, highlighting NLY-I as the most attractive among its peers due to its 8.95% stripped yield and superior 4.989% floating spread. Despite its relative value, NLY-I is still considered outside the buy range by the author, trading …

Verisk Analytics Inc. stock outperforms competitors on strong trading day

Verisk Analytics Inc. (VRSK) saw its stock increase by 1.09% to $191.82 on Friday, marking its second consecutive day of gains. This performance outpaced the broader market, with the S&P 500 Index rising 0.62% and the Dow Jones Industrial Average rising 0.28% on the …

Why Health Catalyst (HCAT) Shares Are Trading Lower Today

Health Catalyst (HCAT) shares fell 23.1% after the company issued a weak third-quarter revenue forecast and lowered its full-year outlook, despite exceeding second-quarter revenue expectations. The reduced guidance overshadowed the company's Q2 performance and indicates significant challenges ahead. This significant drop follows a recent …

Verisk Analytics (VRSK) Balances Lower Q2 Earnings With Buybacks and Dividends: What Story Does That Tell?

Verisk Analytics reported higher Q2 2026 sales but lower net income, yet reaffirmed full-year revenue guidance and an annual dividend of US$2.00 per share. The company has continued significant share buybacks totaling over US$7.27 billion since 2022. Despite these efforts and a leadership change, …

Health Catalyst Shares Tumble Overnight: What Investors Need to Know

Health Catalyst (HCAT) shares plummeted 24.68% in overnight trading after the company issued lower-than-expected third-quarter revenue guidance, despite exceeding its second-quarter revenue guidance. The healthcare intelligence company reported a 13% year-over-year revenue decline in Q2 but saw adjusted EBITDA increase. Investors reacted negatively to …

Compared to Estimates, Health Catalyst (HCAT) Q2 Earnings: A Look at Key Metrics

Health Catalyst (HCAT) reported Q2 2026 revenue of $70.49 million, exceeding the Zacks Consensus Estimate by 2.33%, despite a 12.7% year-over-year decline. The company's EPS of $0.04 surpassed the consensus estimate of $0.02 by 100%. Key metrics like professional services revenue and adjusted gross …

Catalyst Bancorp Inc (CLST) Stock News Today

This article provides current stock information for Catalyst Bancorp Inc (CLST), noting its recent trading activity and key financial metrics. It highlights that more news is expected soon regarding the company's stock, earnings, analyst ratings, and developments.

Verisk Analytics CEO Lee Shavel Sells 2,500 Shares for $550,000

Verisk Analytics CEO Lee Shavel sold 2,500 shares of the company's common stock for $550,000 on July 29, 2026. This transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted in December 2025 and is not considered a cause for concern for investors. …

QUALYS, INC. : RBC RAISES TARGET PRICE TO $180 FROM $145

RBC has increased its target price for Qualys, Inc. (QUALYS) from $145 to $180. This indicates a positive outlook from the firm regarding Qualys's future stock performance. The report was issued by Reuters.

FRACTAL ANALYTICS LIMITED (FRACTAL.NS) stock price, news, quote and history

Notícias das Ações da Verisk Analytics Inc (VRSK)

Kalyani Steels Q1 Results: Profit, EBITDA rise as margins improve; stock falls